Previous close | 4.0700 |
Open | 4.4000 |
Bid | 1.5000 |
Ask | 5.6000 |
Strike | 65.00 |
Expiry date | 2024-10-18 |
Day's range | 4.0700 - 4.4000 |
Contract range | N/A |
Volume | |
Open interest | 9 |
Here is how Bicycle Therapeutics PLC Sponsored ADR (BCYC) and Twist Bioscience (TWST) have performed compared to their sector so far this year.
Amgen's (AMGN) Blincyto is now approved for the treatment of adult and pediatric patients one month and older with Philadelphia chromosome-negative B-ALL in the consolidation phase, regardless of MRD status.
We can readily understand why investors are attracted to unprofitable companies. Indeed, Twist Bioscience ( NASDAQ:TWST...